- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00818636
Expressive Writing for Co-Occurring Depression and Alcohol Misuse
***Please note that this study does not offer comprehensive treatment program for alcohol abuse or depression. Please do not contact the study staff if you are seeking psychological treatment. Further, this study is only enrolling people who are clients at Career and Recovery Resources, Inc., in Houston.
The hypothesis is that writing about feelings and thoughts will help people who are in group treatment feel less depressed and abuse alcohol less.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77004
- Career and Recovery Resources, Inc.
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
***Please note that this study does not offer comprehensive treatment program for alcohol abuse or depression. Please do not contact the study staff if you are seeking psychological treatment. Further, this study is only enrolling people who are clients at Career and Recovery Resources, Inc., in Houston.
Inclusion Criteria:
- Enrolled in group therapy program at Career and Recovery Resources, Inc.
- Must be at least 18.
- Willing and able to participate in the study through the one month follow up.
- Able to provide the contact information of at least two people who can generally locate their whereabouts.
- Speak English fluently.
Exclusion Criteria:
- Inability to read, write, speak English.
- History of bipolar or psychotic disorders.
- Severe medical, cognitive and /or psychiatric impairment that precludes cooperation with study protocol.
- Substance withdrawal symptoms requiring medical attention.
- Currently receiving other individual psychosocial therapy outside of C&R for substance abuse or other psychiatric conditions with the exception of AA, NA or CA.
- Impending incarceration or other factor that would create inability or unwillingness to participate in the 6 week long study period (e.g., halfway house or other aftercare program restrictions).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Expressive Writing
In addition to attending group therapy as usual, participants write about their feelings about an issue of their choosing three times during a two week period for at least 20 minutes each time.
|
Participants in the expressive writing condition write about their feelings about an issue of their choosing three times, for at least 20 minutes each time, during a two week period.
|
|
Aktiv komparator: Treatment as Usual
Participants attend group therapy as usual only.
|
Participants in the expressive writing condition write about their feelings about an issue of their choosing three times, for at least 20 minutes each time, during a two week period.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Beck Depression Inventory, Second Edition
Tidsram: Baseline, Post-writing (2 weeks post-baseline), and One Month Follow-Up (Six weeks post-baseline)
|
Baseline, Post-writing (2 weeks post-baseline), and One Month Follow-Up (Six weeks post-baseline)
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Number of Alcoholic Drinks Consumed
Tidsram: 30 days pre-baseline compared to 30 days post-intervention
|
30 days pre-baseline compared to 30 days post-intervention
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Carrie L Dodrill, Ph.D., The University of Texas Health Science Center at Houston- ** This contact information should not be used for counseling or informational purposes**
- Studiestol: Angela L Stotts, Ph.D., The University of Texas Health Science Center at Houston- ** This contact information should not be used for counseling or informational purposes**
Publikationer och användbara länkar
Allmänna publikationer
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 1R03AA016819-01A1 (U.S.S. NIH-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .